Roland M. Wenger - Concepedia

Author

Roland M. Wenger

Also Known As

R M Wenger, R WENGER, R Wenger, R. M. WENGER, R. M. Wenger, R. WENGER, R. Wenger, R.M. WENGER, R.M. Wenger, ROLAND M. WENGER

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Sanden (Japan)Institut de Biologie Moléculaire et Cellulaire Centre National de la Recherche Scientifique Université du Québec à Montréal

About

Roland M. Wenger is an author at Sanden (Japan) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	1.7K
2	Biochemistry	18	23	1.2K
3	Natural Sciences	14	16	1K
4	Engineering	2	2	123
5	Health Sciences	1	1	129

Roland M. Wenger

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Interactions of Cyclophilin with the Mitochondrial Inner Membrane and Regulation of the Permeability Transition Pore, a Cyclosporin A-sensitive Channel Annamaria Nicolli, Emy Basso, Valeria Petronilli, Journal of Biological Chemistry	1996	480
Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions Andreas Billich, F Hammerschmid, P. Peichl, Journal of Virology Human Immunodeficiency VirusMedicineHuman RetrovirusImmunologyAntiviral Response	1995	173
Synthesis of cyclosporine. Total syntheses of ‘cyclosporin A’ and ‘cyclosporin H’, two fungal metabolites isolated from the species <i>Tolypocladium inflatum</i> G<scp>AMS</scp> Roland M. Wenger Helvetica Chimica Acta Medicinal FungiFungal MetabolitesOrganic ChemistryPeptide ScienceChemistry	1984	159
Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity Valérie F.J. Quesniaux, Max H. Schreier, Roland M. Wenger, European Journal of Immunology	1987	148
Synthesis of Cyclosporine and Analogues: Structural Requirements for Immunosuppressive Activity Roland M. Wenger Angewandte Chemie International Edition in English ImmunologyPeptide ScienceImmunotherapeuticsImmune SystemChemical Biology	1985	137
Immunosuppressive and Nonimmunosuppressive Cyclosporine Analogs Are Toxic to the Opportunistic Fungal Pathogen<i>Cryptococcus neoformans</i>via Cyclophilin-Dependent Inhibition of Calcineurin Maria Cristina Cruz, Maurizio Del Poeta, Ping Wang, Antimicrobial Agents and Chemotherapy Microbial PathogensImmunologyCyclophilin-dependent InhibitionMedicinal FungiCell Culture	2000	129
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent Roger G. Ptak, Philippe Gallay, Dirk Jochmans, Antimicrobial Agents and Chemotherapy ImmunologyAntiviral DrugSynthetic CyclosporineImmunotherapyDrug Resistance	2008	113
P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules U. Schramm, Gert Fricker, Roland M. Wenger, American Journal of Physiology-Renal Physiology Pharmaceutical ScienceGlycobiologyCyclosporin ACellular PharmacologyCytoskeleton	1995	111
Synthesis of Cyclosporine. I. Synthesis of enantiomerically pure (2<i>S</i>,3<i>R</i>,4<i>R</i>,6<i>E</i>)‐3‐hydroxy ‐4‐methyl‐2‐methylamino‐6‐octenoic acid starting from tartaric acid Roland M. Wenger Helvetica Chimica Acta Tartaric AcidBioorganic ChemistryOrganic ChemistryPeptide ScienceChemistry	1983	90
Modification of Cyclosporin A (CS): Generation of an enolate at the sarcosine residue and reactions with electrophiles Dieter Seebàch, Albert K. Beck, Hans G. Bossler, Helvetica Chimica Acta Cyclosporin AOrganic ChemistryPeptide ScienceChemistryPharmaceutical Chemistry	1993	83

Page 1